BCTXW

Jun 3, 2026, 00:00 UTC

BriaCell Therapeutics Corp. completed a best-efforts follow-on offering of 1,449,300 common shares at $3.25 per share for gross proceeds of $4.71 million, with ThinkEquity LLC as placement agent.